Anzeige
Mehr »
Mittwoch, 11.02.2026 - Börsentäglich über 12.000 News
Drohnen, Robotik, E-Autos: Diese Hightech-Aktie könnte jetzt zünden
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
485 Leser
Artikel bewerten:
(2)

MediQuant Achieves HITRUST Risk-based, 2-year Certification Demonstrating the Highest Level of Information Protection Assurance

HITRUST Risk-based, 2-year (r2) Certification validates MediQuant is committed to strong cybersecurity and meeting key regulations to protect sensitive data

INDEPENDENCE, OH / ACCESSWIRE / August 18, 2023 / MediQuant, LLC, a leading provider of enterprise data archive technology for the healthcare industry and creator of DataArk®, today announced the MediQuant Healthcare Data Lifecycle Platform has earned certified status by HITRUST for information security.

HITRUST Risk-based, 2-year (r2) Certified status demonstrates that the organization's Healthcare Data Lifecycle Platform including the DataArk®, ApplicationArk and PatientArchive® technology solutions, has met demanding regulatory compliance and industry-defined requirements and is appropriately managing risk. This achievement places MediQuant in an elite group of organizations worldwide that have earned this certification. By including federal and state regulations, standards, and frameworks, and incorporating a risk-based approach, the HITRUST Assurance Program helps organizations address security and data protection challenges through a comprehensive and flexible framework of prescriptive and scalable security controls.

"Secure healthcare data archiving is essential to the protection of confidential patient information, which is why our team has gone the extra mile to ensure we meet complex compliance, information protection, and privacy requirements," said Jim Jacobs, President and CEO of MediQuant. "We are pleased to demonstrate to our customers the highest standards for data protection and information security by achieving the rigorous HITRUST Risk-based, 2-year Certification."

MediQuant's capabilities traverse the continuum of an organization's data lifecycle, including storage of non-discrete documents such as scanned PDFs, to discrete static data such as lab results, to active access to discrete data like financials. The company's core platform solutions, which includes MediQuant's flagship solution, DataArk®, offer access to a common data repository that is secure, intuitive, and scalable, providing an active view of patient records from within current systems. MediQuant solutions can be deployed by the full spectrum of healthcare entities from large hospitals to multi-facility health systems, ambulatory centers, physician practices, home health agencies, and more.

"The HITRUST Assurance Program is rigorous and reliable because of the comprehensiveness of control requirements, depth of review, and consistency of oversight," said Bimal Sheth, Executive Vice President, Standards Development & Assurance Operations, HITRUST. "HITRUST Risk-based, 2-year (r2) Certification demonstrates MediQuant is taking the most proactive approach to cybersecurity, data protection, and risk management."

About MediQuant
Founded in 1999, MediQuant is the leader in enterprise active archiving solutions for hospitals and health systems. The Company's flagship product, DataArk®, assists hospitals in retiring legacy clinical, patient accounting and ERP platforms while maintaining access to critical data via a cloud-based software platform. MediQuant's entire suite of core platform applications offer access to a common data repository that is secure, intuitive, and scalable, providing an active view of patient records from within your current systems. Rigorous operational requirements ranging from business intelligence and analytics to interoperability demands, compliant medical records access, accounting tasks and clinical access, are met effortlessly through the MediQuant platform. With decades of experience successfully executing data conversions, migrations and archives across virtually all major EMR, EHR, ERP and Patient Accounting software vendors, MediQuant serves 250+ individual health systems, which represent more than 1,100 hospital and physician practice customers. For more information, visit www.mediquant.com.

###

Press contact information:
Tom Testa
Anderson Interactive
tom@andersoni.com

Amy Glass
MediQuant
aglass@mediquant.com

SOURCE: MediQuant

View source version on accesswire.com:
https://www.accesswire.com/775035/MediQuant-Achieves-HITRUST-Risk-based-2-year-r2-Certification-Demonstrating-the-Highest-Level-of-Information-Protection-Assurance

© 2023 ACCESS Newswire
Favoritenwechsel
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.